Ownership history in Parsifal Capital Management, LP · 8 quarters on record
This page tracks every 13F SEC filing in which Parsifal Capital Management, LP reported a position in TEVA PHARMACEUTICAL INDS LTD (TEVA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 2,819,933 | +809,426 | +40.3% | 7.22% | $88.0M | $31.21 |
| 2025 Q3 | REDUCED | 2,010,507 | -890,123 | -30.7% | 3.78% | $40.6M | $20.20 |
| 2025 Q2 | REDUCED | 2,900,630 | -1,301,557 | -31.0% | 4.12% | $48.6M | $16.76 |
| 2025 Q1 | REDUCED | 4,202,187 | -169,814 | -3.9% | 5.59% | $64.6M | $15.37 |
As of 2025 Q4 — sorted by position size